21 May 2026
21 May 2026
The new specialist firm will operate across the North American, APAC and European markets, which make up around 90% of the global R&D spend.
Lilly’s takeover of Engage Bio marks the seventh acquisition for the big pharma since the start of 2026.
BMS will roll out Claude to over 30,000 employees, targeting three main areas for near-term impact.
The site includes laboratories for cell culture manufacturing, process development, and a centre focused on gene editing.
PABPC4 genetic variants found to be associated with mitochondrial dysfunction driving emphysema in COPD.
48 weeks of Trikafta treatment improved lung capacity and inflammation biomarkers among CF patients.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.
